Similar articles

• [Chronic inflammatory bowel diseases. Update on evidence-based therapy].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2005 Apr 28;147(17):58-9. MMW Fortschr Med. 2005. PMID: 15903063 German. No abstract available.
• [Recurrence-preventive (remission preserving) therapy of chronic inflammatory bowel diseases].

  Kruis W, Pohl C. Kruis W, et al. Dtsch Med Wochenschr. 1998 Jan 23;123(4):85-7. doi: 10.1055/s-2007-1023902. Dtsch Med Wochenschr. 1998. PMID: 9487288 German. No abstract available.
• Sulfasalazine and new analogues in inflammatory bowel disease, with focus on Crohn's disease.

  van Hees PA. van Hees PA. Acta Gastroenterol Belg. 1987 Sep-Oct;50(5):555-9. Acta Gastroenterol Belg. 1987. PMID: 2902723 No abstract available.
• [New developments in the treatment of inflammatory bowel diseases. What is certain?].

  Feurle GE. Feurle GE. Z Gastroenterol Verh. 1990 Apr;25:150-2. Z Gastroenterol Verh. 1990. PMID: 1694355 Review. German. No abstract available.
• Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.

  Lauritsen K. Lauritsen K. Dan Med Bull. 1989 Sep;36(4):378-93. Dan Med Bull. 1989. PMID: 2572403 Review. No abstract available.